J. Scott Roberts, Ph.D.
- Professor, Health Behavior & Health Education
- Director, Certificate in Public Health Genetics Program
- Co-Director, Dual-Degree (MPH/MS) Program in Public Health and Genetic Counseling
- Director, ELSI Research Training Program
- Room 2834, SPH I
- 1415 Washington Heights
- Ann Arbor, Michigan 48109-2029
Dr. Roberts is Professor in the Department of Health Behavior & Health Education (HBHE) and Director of the SPH Public Health Genetics Certificate program. Prior to joining the HBHE faculty in Fall 2006, he was Assistant Professor in the Department of Neurology at Boston University (BU) School of Medicine. At U-M, he serves as a Co-Director of the U-M dual-degree program in Public Health and Genetic Counseling and a core faculty member in the U-M Center for Bioethics & Social Sciences in Medicine. He also directs the Outreach, Recruitment and Education Core of the NIH-funded Michigan Alzheimer's Disease Center. Finally, Dr. Roberts serves as Program Director of the U-M ELSI Research Training Program. This NIH-funded T32 training grant provides support for predoctoral and postdoctoral fellows with interests in the ethics, legal, and social implications (ELSI) of advances in genomic science and technology.
- Ph.D., Clinical Psychology, University of Michigan, 1999
- M.A., Clinical Psychology, University of Michigan, 1996
- B.A., English, Duke University, 1992
Research Interests & Projects
- Roberts JS, Robinson JO, Diamond PM, Bharadwaj A, Christensen KD, Lee KB, Green RC, McGuire AL. (2018, January 4). Patient understanding of, satisfaction with, and perceived utility of whole genome sequencing: Findings from the MedSeq Project. Genetics in Medicine, e-pub ahead of print.
- Christensen KD, Uhlmann WR, Roberts JS, et al. (2018). A randomized controlled trial of disclosing genetic risk information for Alzheimer's disease via telephone. Genetics in Medicine, 20(1), 132-41.
- Roberts JS, Gornick MC, Carere DA, Uhlmann WR, Ruffin MT, Green RC (2017, January 10). Direct-to-consumer genetic testing: User motivations, decision making, and perceived utility of results. Public Health Genomics, e-pub ahead of print.
- Christensen KD, Roberts JS, Whitehouse PJ, et al. (2016). Disclosing pleiotropic effects during genetic risk assessment for Alzheimer's disease: A randomized, controlled trial. Annals of Internal Medicine, 164, 155-163.
- Roberts, JS, Dolinoy, DC & Tarini, BA (2014). Emerging issues in public health genomics. Annual Review of Genomics and Human Genetics, 15, 461-480.
- Roberts, JS, Connell, CM, & McLaughlin, S (2014). Public knowledge and beliefs about risk and protective factors for Alzheimer's disease: Findings from the Health and Retirement Study. Alzheimer's and Dementia, 10(5) S381-S389.
- Roberts JS, Dunn L, & Rabinovici, G (2013). Amyloid imaging, risk disclosure, and Alzheimer's disease: Ethical and practical issues. Neurodegenerative Disease Management, 3(3) 219-229.
- Roberts JS, & Uhlmann WR (2013). Genetic susceptibility testing for neurodegenerative diseases: Ethical and practice issues. Progress in Neurobiology. 110, 89-101.
- Roberts JS, Chen C, Uhlmann W, & Green RC (2012). Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer's disease: The REVEAL Study. Genetics In Medicine, 14, 742-748.
- Roberts JS, Christensen KD, Green RC (2011). Using Alzheimer's disease as a model for genetic risk disclosure: Implications for personal genomics Clinical Genetics, 80, 407-414.
- Roberts, JS, Shalowitz, DI, Christensen, KD, Everett, J, Kim, S, Raskin, L, Gruber, SB (2010). Returning individual research results: Development of a cancer genetics education and risk communication protocol. Journal of Empirical Research on Human Research Ethics, 3, 17-30.
- Roberts, JS, Karlawish, J, Uhlmann, W, Petersen, R, Green, RC (2010). Mild cognitive impairment in clinical care: A survey of neurologists' attitudes and practices. Neurology, 75, 425-431.
- Roberts, JS, Tersegno, S (2010). Estimating and disclosing the risk of developing Alzheimer's disease: Challenges, controversies and future directions. Future Neurology, 5, 501-517.
- Green, R, Roberts, JS, et al. (2009). A randomized trial of APOE disclosure for risk of Alzheimer's disease: The REVEAL Study. New England Journal of Medicine, 361, 245-254.
- American Public Health Association
- American Society of Bioethics and the Humanities
- International Society to Advance Alzheimer's Research & Treatment
Rabid Duke basketball fan